SIGLEC-3 (CD33) Serves As an Effective Target in Tumor Progression
JOURNAL OF IMMUNOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined